On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during a special virtual awards session. Gary Crocker, president of Crocker Ventures, was honored with a Lifetime Achievement Award Other distinguished award winners include Salt Lake City Mayor Erin Mendenhall; Chris Gibson, CEO, Recursion Pharmaceuticals; Randy Rasmussen, co-founder, […]
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test allows simultaneous detection of human antibodies to the SARS-CoV-2 S1 protein and the SARS-CoV-2 S2 protein, which has shown measurable improvement in clinical performance, compared to tests using a single protein. “This is very welcome news, said […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors. “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas. Dr. Richard Saxon, FSIR and member of the SDI Medical Group, while working at Tri City Medical Center Medical Center, Oceanside, California, USA performed the first procedures using […]
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors. “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]
On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]
CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that the first patient has been dosed with TP-1454, an investigational small-molecule pyruvate kinase M2 isoform (PKM2) activator, administered alone and in combination with ipilimumab and nivolumab, in a Phase 1/1b study in patients with advanced […]
On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2. “By investing in our human resources and equipment, […]
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]